The EORTC's PROLoNG phase III trial, initiated by P. Balermpas, is going to evaluate the combination of pembrolizumab + SBRT for oligometastatic HNSCC. Stay tuned!
05.01.2025 15:20 — 👍 0 🔁 0 💬 0 📌 0
💡 Key Highlights:
➡️ 16 centers from 🇩🇪 🇦🇹 🇨🇭
➡️ 178 pts w/ oligometastatic HNSCC receiving SBRT of 284 lung mets
➡️ 5.5% 1-year cumulative incidence of local failures
➡️ BED ≥100 Gy associated with fewer local failures (sHR, 0.17; p=.006)
➡️ Median OS and PFS were 33 months and 9 months, respectively
05.01.2025 15:17 — 👍 0 🔁 0 💬 1 📌 0
DEFINE_ME
Our latest study, "Pulmonary Stereotactic Body Radiotherapy (SBRT) of Oligometastatic Head-and-Neck Squamous Cell Carcinoma (HNSCC): A Multicenter Retrospective Study", is now available in the @ijrobp.bsky.social
www.redjournal.org/article/S036...
05.01.2025 15:13 — 👍 4 🔁 2 💬 1 📌 0
The Princess Margaret Cancer Centre is Canada’s largest integrated cancer research, teaching, and treatment centre, one of the top cancer research centres in the world and is one of the University Health Network’s six research institutes.
The European Association for Cancer Research has 14,000+ members. Our aim? Advancing cancer research 🥼🔬🌍 #KeepResearchCurious
www.eacr.org
The mission of the American Association for Cancer Research (AACR) is to prevent and cure cancer through research, education, communication, collaboration, science policy and advocacy, and funding for cancer research.
ASTRO: The American Society for Radiation Oncology.
Targeting Cancer Care.
ASTRO website: http://ASTRO.org
Patient education info at http://RTanswers.org
#radonc #medphys #radbio #DEIinRO
Practical imaging software for Radiation Oncology, Radiology, Nuclear Medicine, Theranostics, Interventional Radiology, and Urology.
MIM offers intuitive, automated solutions that help clinicians make more confident patient care decisions in less time.
MD, MPH - Lung Cancer Specialist and Professor, David Geffen School of Medicine at UCLA | Co-Director, Lung Precision Oncology Program, VA Greater Los Angeles
https://www.uclahealth.org/radonc/drew-moghanaki
Professor, Radiotherapy Medical Physicist, Lab PI, Childhood Cancer Survivorship Researcher @mdanderson.bsky.social
#medphys #radonc
Medical Physics Program Director @mda-uthgrad.bsky.social
Sonderpädagogin im Bereich Lernen bei Blindheit und Beeinträchtigung des Sehens, überwiegend im Sonderpädagogischen Dienst in #edubw tätig, Multimediaberaterin, #iPad im Bereich Low Vision, Schulentwicklung & MEP
#radonc & Strategy VC at UCSF @ucsfmedicine.bsky.social @ucsfcancer.bsky.social, for lung #lcsm and head and neck cancer #hncsm, Committee Chair at NRG Oncology #NRGOnc, EIC of #IJROBP @ijrobp.bsky.social aka The Red Journal at ASTRO @astro-org.bsky.social
I do not check this account. Find me on Twitter, LinkedIn, or www.sprakermd.com
The International Journal of Radiation Oncology * Biology * Physics
Please tag #IJROBP and add to our community/feed!
#radonc @astro-org.bsky.social #RedJournal
This month: www.redjournal.org/current
Podcasts: https://www.redjournal.org/multimedia/audio
Radiation oncologist/ Ass.Professor/ University Marburg 🇩🇪/ #Radonc
Prostate oncologist, cyclist, budding climate activist, croquet player
Physicist, cancer & radiotherapy researcher, trialist, data nerd. Global low-carbon / train traveller. Occasional caver & underground photographer. Professor of Clinical Medical Physics at Rigshospitalet & DTU, Copenhagen, DK #radonc #medphys
Radiation Oncologist • Chair of department and Professor @amsterdamumc • Passionately redefining Radiotherapy • Ethos, Truebeam, MRIdian, Brachytx, Hyperthermia
